Simulations Plus to distribute quarterly cash dividend in May 2013

Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its Board of Directors has decided to distribute a cash dividend in May.

“The Board of Directors has demonstrated that it believes in rewarding our loyal shareholders by returning a portion of our excess cash in the form of dividends. As our financial performance improves, the board will consider further increases.”

The Board of Directors declared its next ongoing quarterly cash dividend of $0.03 per share, an increase of $0.01 per share over the $0.02 per share that was planned after the accelerated dividend distribution of $0.03 per share for the expected May, August, and November 2013 distributions. This dividend will be distributed on Friday, May 10, 2013, for shareholders of record as of Tuesday, May 7, 2013.

Ms. Momoko Beran, chief financial officer of Simulations Plus, said: "The board has decided to increase the dividend to shareholders as a result of our excellent financial performance during the second fiscal quarter of fiscal year 2013, as reported in our 10-Q filed on April 10, 2013. We generated more than one million dollars in net income in the second quarter, and this dividend increase amounts to about $160,000."

Walt Woltosz, chairman and chief executive officer of Simulations Plus, added, "The Board of Directors has demonstrated that it believes in rewarding our loyal shareholders by returning a portion of our excess cash in the form of dividends. As our financial performance improves, the board will consider further increases."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research from second pig heart transplant provides new directions for xenotransplantation